Serological evidence of MERS-CoV antibodies in dromedary camels (camelus dromedaries) in laikipia county, Kenya

49Citations
Citations of this article
132Readers
Mendeley users who have this article in their library.

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) is a recently identified virus causing severe viral respiratory illness in people. Little is known about the reservoir in the Horn of Africa. In Kenya, where no human MERS cases have been reported, our survey of 335 dromedary camels, representing nine herds in Laikipia County, showed a high seroprevalence (46.9%) to MERS-CoV antibodies. Between herd differences were present (14.3%- 82.9%), but was not related to management type or herd isolation. Further research should focus on identifying similarity between MERS-CoV viral isolates in Kenya and clinical isolates from the Middle East and elsewhere.

Cite

CITATION STYLE

APA

Deem, S. L., Fèvre, E. M., Kinnaird, M., Browne, A. S., Muloi, D., Godeke, G. J., … Reusken, C. B. (2015). Serological evidence of MERS-CoV antibodies in dromedary camels (camelus dromedaries) in laikipia county, Kenya. PLoS ONE, 10(10). https://doi.org/10.1371/journal.pone.0140125

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free